111 related articles for article (PubMed ID: 1331472)
1. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes.
Armstrong SC; Ganote CE
J Mol Cell Cardiol; 1992 Aug; 24(8):869-84. PubMed ID: 1331472
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia.
Armstrong SC; Gao W; Lane JR; Ganote CE
J Mol Cell Cardiol; 1998 Jan; 30(1):61-73. PubMed ID: 9500865
[TBL] [Abstract][Full Text] [Related]
3. Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes.
Armstrong SC; Shivell LC; Ganote CE
J Mol Cell Cardiol; 2001 Jan; 33(1):149-60. PubMed ID: 11133231
[TBL] [Abstract][Full Text] [Related]
4. Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.
Armstrong SC; Ganote CE
Am J Pathol; 1991 Mar; 138(3):545-55. PubMed ID: 2000934
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia.
Armstrong SC; Ganote CE
J Mol Cell Cardiol; 1991 Sep; 23(9):1001-14. PubMed ID: 1942093
[TBL] [Abstract][Full Text] [Related]
6. Irreversible injury of isolated adult rat myocytes. Osmotic fragility during metabolic inhibition.
Ganote CE; Vander Heide RS
Am J Pathol; 1988 Aug; 132(2):212-22. PubMed ID: 3400772
[TBL] [Abstract][Full Text] [Related]
7. Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes.
Frace AM; Hartzell HC
J Physiol; 1993 Dec; 472():305-26. PubMed ID: 8145146
[TBL] [Abstract][Full Text] [Related]
8. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils.
Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A
Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781
[TBL] [Abstract][Full Text] [Related]
10. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
[TBL] [Abstract][Full Text] [Related]
11. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition.
Ruiz-Meana M; García-Dorado D; González MA; Barrabés JA; Soler-Soler J
Cardiovasc Res; 1995 Jul; 30(1):64-9. PubMed ID: 7553725
[TBL] [Abstract][Full Text] [Related]
12. Effects of calcium depletion and loading on injury during metabolic inhibition of isolated adult rat myocytes.
Rim DS; Altschuld RA; Ganote CE
J Mol Cell Cardiol; 1990 Feb; 22(2):227-37. PubMed ID: 2109081
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid-induced decrease in the magnitude and efficacy of the Ca2+ signal in pancreatic beta cells and inhibition of insulin secretion.
Sato Y; Mariot P; Detimary P; Gilon P; Henquin JC
Br J Pharmacol; 1998 Jan; 123(1):97-105. PubMed ID: 9484859
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia.
Armstrong S; Ganote CE
Cardiovasc Res; 1994 Nov; 28(11):1700-6. PubMed ID: 7842465
[TBL] [Abstract][Full Text] [Related]
17. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
Lerea KM
Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibitory effects of serine/threonine phosphatase inhibitors and a calmodulin antagonist on phosphoinositol/calcium- and cyclic adenosine monophosphate-mediated pancreatic amylase secretion.
Meyer-Alber A; Höcker M; Fetz I; Fornefeld H; Waschulewski IH; Fölsch UR; Schmidt WE
Scand J Gastroenterol; 1995 Apr; 30(4):384-91. PubMed ID: 7541915
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor.
Neumann J; Bokník P; Herzig S; Schmitz W; Scholz H; Wiechen K; Zimmermann N
J Pharmacol Exp Ther; 1994 Oct; 271(1):535-41. PubMed ID: 7965753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
